May was Bladder Cancer Awareness Month, so we wanted to share a conversation with Dr. Yair Lotan on the state of bladder cancer awareness and research, his work with the Bladder Cancer Advocacy Network, and some of the advancements in bladder cancer research that most excite him.
Dr. Lotan is a urology professor and chief of urologic oncology at University of Texas Southwestern Medical Center in Dallas, Texas. He’s known nationally for his research on urine markers and molecular markers, which will help determine patients at higher risk for recurrent cancer.
Bladder cancer is the sixth most common cancer diagnosed annually in the U.S., according to the National Library of Medicine.
This is the second part of a two-part conversation we conducted with Dr. Lotan. In the first, we discussed a micro-cost analysis published in Urology that broke down per-procedural costs for cystoscopy and explored how single-use cystoscopes might provide a cost-effective option for providers.
Dr. Lotan is an Ambu consultant.
Show notes:
------------------------
Endoscopy Insights is a podcast devoted to conversations with thought leaders in flexible and single-use endoscopy. In each episode we’ll explore the ways different clinical and technological innovations are moving the field of endoscopy forward.
Endoscopy Insights is brought to you by Single-Use Endoscopy, part of the Ambu Learning Center. Ambu has been bringing healthcare solutions of the future to life since 1937.
.png)
A Learning Center by Ambu USA
